Avai Bio (AVAI) Preferred Shares (2020 - 2025)

Avai Bio has disclosed Preferred Shares across 6 years of filings, most recently posting $15250.0 for Q4 2025.

• Preferred Shares for Q4 2025 came in at $15250.0, down 99.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $15250.0 (down 99.87% YoY), and the FY2025 annual result was $11300.0, down 99.89% from the prior year.
• Preferred Shares came in at $15250.0 for Q4 2025 at Avai Bio, roughly flat from $15250.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $11.3 million in Q4 2024 to a low of $3950.0 in Q1 2021.
• The 5-year median for Preferred Shares is $10000.0 (2023), against an average of $1.4 million.
• Across the five-year window, Preferred Shares soared 253064.56% in 2024 and slumped 99.89% in 2025, its largest moves.
• Avai Bio's Preferred Shares stood at $3950.0 in 2021, then changed by 0.0% to $3950.0 in 2022, then soared by 153.16% to $10000.0 in 2023, then soared by 112900.0% to $11.3 million in 2024, then sank by 99.87% to $15250.0 in 2025.
• The last three Preferred Shares figures came in at $15250.0 (Q4 2025), $15250.0 (Q3 2025), and $15250.0 (Q2 2025), per Business Quant data.